BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38595838)

  • 1. Role of
    Shrinivas Y; Palaniswamy SS; Subramanyam P
    World J Nucl Med; 2024 Mar; 23(1):49-53. PubMed ID: 38595838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and Validation of
    Yang X; Lu X; Liu J; Kan Y; Wang W; Zhang S; Liu L; Li J; Yang J
    Korean J Radiol; 2022 Apr; 23(4):466-478. PubMed ID: 35289150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of F-18 FDG PET/CT in patients with secondary hemophagocytic lymphohistiocytosis.
    Kim J; Yoo SW; Kang SR; Bom HS; Song HC; Min JJ
    Ann Hematol; 2014 Apr; 93(4):661-7. PubMed ID: 24061788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Pre-therapeutic
    Lu X; Wei A; Yang X; Liu J; Li S; Kan Y; Wang W; Wang T; Zhang R; Yang J
    Front Med (Lausanne); 2021; 8():836438. PubMed ID: 35127776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. F-18 FDG PET/CT in NK/T-Cell Lymphoma that Progressed from Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Kim IH; An YS; Lee SJ; Yoon JK
    Nucl Med Mol Imaging; 2022 Feb; 56(1):59-62. PubMed ID: 35186160
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
    Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple-Organ Involvement in Familial Hemophagocytic Lymphohistiocytosis Type 2 Shown on FDG PET/CT.
    Wang W; Yang X; Yang J
    Clin Nucl Med; 2021 Nov; 46(11):935-937. PubMed ID: 34034321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
    Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
    Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
    Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype-Guided
    Wu S; Wang Y; Li J; Zhang N; Mo M; Klimberg S; Kaklamani V; Cochet A; Shao Z; Cheng J; Liu G
    Oncologist; 2020 Apr; 25(4):e626-e633. PubMed ID: 32297448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis Mimicking Lymphoma on FDG PET/CT.
    Pan Q; Luo Y; Wu H; Ma Y; Li F
    Clin Nucl Med; 2018 Feb; 43(2):125-127. PubMed ID: 29215415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Value of
    Ding CY; Liu HY; Guo Z; Li YY; Yang WP; Li TN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):133-137. PubMed ID: 28245389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.
    Povoski SP; Hall NC; Murrey DA; Wright CL; Martin EW
    BMC Cancer; 2015 May; 15():378. PubMed ID: 25953144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 18F-FDG PET/CT for staging and response assessment of primary parotid MALT lymphoma with multiple sites involvement: A case report.
    Ren Y; Huang L; Han Y; Cui Z; Li J; Dong C; Liu J
    Medicine (Baltimore); 2019 Feb; 98(5):e14270. PubMed ID: 30702589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the role of bone marrow increased FDG uptake on PET/CT in patients with lymphoma-associated hemophagocytic lymphohistiocytosis: a reflection of bone marrow involvement or cytokine storm?
    Yang YQ; Ding CY; Xu J; Fan L; Wang L; Tian T; Li TN; Li JY; Xu W
    Leuk Lymphoma; 2016 Feb; 57(2):291-298. PubMed ID: 25989865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness and pitfalls of F-18-FDG PET/CT for diagnosing extramedullary acute leukemia.
    Zhou WL; Wu HB; Wang LJ; Tian Y; Dong Y; Wang QS
    Eur J Radiol; 2016 Jan; 85(1):205-210. PubMed ID: 26724667
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Jiang Y; Wang L; Zhou W; Gu J; Tian Y; Dong Y; Fu L; Wu HB
    Cancer Imaging; 2020 Jan; 20(1):4. PubMed ID: 31924270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Report of Eleven Patients of Subcutaneous Panniculitis-Like T-Cell Lymphoma: Clinicopathologic Features,
    Jiang M; Zhao L; Zheng J; Zhang J; Chen P; Zhou W
    Front Oncol; 2021; 11():650822. PubMed ID: 34277404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid Sarcoma and Acute Myelomonocytic Leukemia in an Adolescent with Tetrasomy 8: Staging with (18)F-FDG PET/CT.
    Makis W; Rakheja R; Lavoie J; Hickeson M
    Nucl Med Mol Imaging; 2012 Jun; 46(2):119-24. PubMed ID: 24900045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.